Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585039 · ClinicalTrials.gov registry record · Phase 4
Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
A Phase 4 study, sponsored by Phoenix Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 101
- Enrollment target
NCT00585039 is a Phase 4 study that has completed, run by Phoenix Children's Hospital. The registered enrollment target is 101 participants.
The verdict
NCT00585039, a Phase 4 study, has completed, sponsored by Phoenix Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to determine in a large, double-blind, randomized, prospective pediatric clinical trial whether the use of continuous levalbuterol (Xopenex) in addition to standard emergency department treatment for acute asthma exacerbations will improve the Forced Expiratory Volume in 1 sec (FEV 1) compared to the use of continuous racemic albuterol. The secondary objective is to correlate clinical (hospitalization rates and clinical asthma scores) with plasma levels of (S)-albuterol.
Interventions
- DRUG xopenex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585039
The ClinicalTrials.gov registry entry for NCT00585039 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phoenix Children's Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which xopenex is the first listed.
NCT00585039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585039 about?
NCT00585039 is a clinical study titled "Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)". The purpose of this study is to determine in a large, double-blind, randomized, prospective pediatric clinical trial whether the use of continuous levalbuterol (Xopenex) in addition to standard emergency department treatment for acute asthma exacerbations will improve the Forced Expiratory Volume in...
What is the current status of trial NCT00585039?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 101 participants. The study started on 2005-09. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00585039?
The interventions under investigation include: xopenex (DRUG).
Who is sponsoring clinical trial NCT00585039?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.